Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Regadenoson Stress CMR for CAD Detection
NCT01446094Phase 4Unknown
- Start
- Aug 2011
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD). Status: unknown.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01446094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446094.